Dipexium Pharmaceuticals Inc., of New York, reported that a phase I study testing Locilex (pexiganan acetate cream 1 percent), an antibiotic peptide formulated as a topical cream, in mild infections of diabetic foot ulcers showed the cream was not an irritant.